The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Galan Lithium
GLN:AU
Trident Royalties PLC
TDTRF
Purpose Bitcoin ETF
BTCC:CA
International Graphite
IG6:AU
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
MENAFN.com reported that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has acquired all of MicroDose Therapeutx’s outstanding shares for US$40 million.
MENAFN.com reported that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has acquired all of MicroDose Therapeutx’s outstanding shares for US$40 million.
As quoted in the market news:
MicroDose Therapeutx will receive additional payments of up to USD125m upon achievement of regulatory and development milestones, plus sales-based milestones and tiered royalty payments upon commercialisation of MDT-637 and an earlier stage Asthma/COPD medicine.
A drug delivery company, MicroDose Therapeutx is focused on inhalation technologies and products for lung diseases and infections with the potential to dramatically improve efficacy and patient compliance.
Outlook Reports
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
| Commodities | |||
|---|---|---|---|
| Gold | 2323.45 | -9.95 | |
| Silver | 27.33 | +0.02 | |
| Copper | 4.46 | -0.05 | |
| Oil | 83.42 | +1.52 | |
| Heating Oil | 2.59 | +0.02 | |
| Natural Gas | 1.84 | +0.04 | |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.